1-[2-(4-Aminopiperidin-1-yl)ethyl]-2-oxo-1,2-dihydroquinoline-7-carbonitrile → HCID 66774613, compound
Reaction equation
C(OC(=O)[NH:7][CH:8]1[CH2:13][CH2:12][N:11]([CH2:14][CH2:15][N:16]2[C:21]3[CH:22]=[C:23]([F:27])[CH:24]=[C:25]([F:26])[C:20]=3[O:19][CH2:18][C:17]2=[O:28])[CH2:10][CH2:9]1)(C)(C)C.NC1CCN(CCN2C3C(=CC=C(C#N)C=3)C=CC2=O)CC1>>[NH2:7][CH:8]1[CH2:9][CH2:10][N:11]([CH2:14][CH2:15][N:16]2[C:21]3[CH:22]=[C:23]([F:27])[CH:24]=[C:25]([F:26])[C:20]=3[O:19][CH2:18][C:17]2=[O:28])[CH2:12][CH2:13]1Participants
3
Procedure
tert-Butyl{1-[2-(6,8-difluoro-3-oxo-2,3-dihydro-4H-1,4-benzoxazin-4-yl)ethyl]piperidin-4-yl}carbamate (Intermediate 72) (423 mg, 1 mmol) was reacted as described for Intermediate 14. The crude trifluoro acetate of the title compound was used without further purification for the next step (quantitative yield).
Workup
- customThe crude trifluoro acetate of the title compound was used without further purification for the next step (quantitative yield)
Sources & evidence
- ORD record
- ord-1e11ec3606dc4834bd8ed14bb76c441c
- Source dataset
- uspto-grants-2012_02
- Patent number
- US08124602B2
Reaction notes
Loading…